Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study-Reference-Cited by-同舟云学术

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Published:2018-05 Issue:5 Volume:19 Page:705-714
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Laetsch Theodore W,DuBois Steven G,Mascarenhas Leo,Turpin Brian,Federman Noah,Albert Catherine M,Nagasubramanian Ramamoorthy,Davis Jessica L,Rudzinski Erin,Feraco Angela M,Tuch Brian B,Ebata Kevin T,Reynolds Mark,Smith Steven,Cruickshank Scott,Cox Michael C,Pappo Alberto S,Hawkins Douglas S

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Trk receptor tyrosine kinases: a bridge between cancer and neural development;Nakagawara;Cancer Lett,2001

2. Growth, survival and migration: the Trk to cancer;Rubin;Cancer Treat Res,2003

3. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types;Amatu;ESMO Open,2016

4. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma;Creancier;Cancer Lett,2015

5. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences;Martin-Zanca;Nature,1986

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system;ESMO Real World Data and Digital Oncology;2024-09

2. Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update;Pathology - Research and Practice;2024-08

3. Preclinical Pediatric Molecular Analysis for Therapy Choice (MATCH);2024-07-23

4. Larotrectinib efficacy for liver metastases in papillary thyroid carcinoma patient harboring SQSTM1–NTRK1 fusion;Surgical Case Reports;2024-07-17

5. Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned;Drug Discovery Today;2024-07